Cancer

The Cancer Letter: Will cancer centers remain committed to improving equity in the long term?

July 5, 2021

Dr. Ruben Mesa and Dr. Amelie Ramirez, Mays Cancer Center, are quoted in this story. In his remarks, Dr. Mesa mentions Dr. Chiquita Collins, the first vice dean of inclusion and diversity and chief diversity officer for the Long School of Medicine. Dr. Collins also serves as associate vice president of inclusive excellence and health […]


OncLive: Phase 3 MOMENTUM Study Completes Enrollment in Myelofibrosis

July 5, 2021

Dr. Ruben Mesa, executive director of the Mays Cancer Center, is quoted in this story about a clinical trial. Read more


San Antonio Business Journal: SA cancer center to expand research diversity with national clinical trial

July 1, 2021

Dr. Ruben Mesa, executive director of the Mays Cancer Center, was quoted in this story about the Mays Cancer Center at UT Health San Antonio joining three other institutions to participate in a new Advancing Inclusive Research Site Alliance launched by San Francisco-based Genentech. Read story


Cancer Patient with Cap Photo

Nearly all patients with cancer respond well to COVID-19 vaccines

July 1, 2021

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.



San Antonio Business Journal: Georgia firm, UT Health SA to develop new cancer therapy and research center

June 25, 2021

The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, and Proton International LLC are partnering to build a proton therapy center to provide an advanced alternative to conventional radiation treatment for cancer. Dr. Ruben Mesa, executive director of the Mays Cancer Center, and Dr. Mark Bonnen, chief […]



Mays Cancer Center selected as founding partner of oncology clinical trial diversity alliance

June 23, 2021

The Mays Cancer Center, home to UT Health San Antonio MD Anderson, was named a founding partner of the Advancing Inclusive Research® Site Alliance.